Sign In
test

Stephen Leslie Cohen

Spruce Street Capital Lp

Assets Managed
$415.936M
Holdings
28
Last Quarter
2026 - Q1
Filed Date
7d ago
Growth Rate
37.43%(2Q avg: 18.72%)
Sustained Growth
1 quarters

Portfolio positions

This chart displays the top 10 holdings in Spruce Street Capital Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 28 positions.

Assets under management

The assets under management (AUM) of Spruce Street Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 415.936M in assets, with a quarterly growth rate of 37.43% and a 2-quarter average growth rate of 18.72%. The portfolio is managed by Stephen Leslie Cohen, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
RLMD
Relmada Therapeutics Inc
Recent Activity
Increased 53.26%
10.34%
$42.998M
6.262M shares@ $6.87 avg price
KNSA
Kiniksa Pharmaceuticals Inte
Recent Activity
Increased 74.97%
8.82%
$36.645M
761,063 shares@ $48.15 avg price
LBRX
Lb Pharmaceuticals Inc
Recent Activity
Increased 36.86%
8.09%
$33.645M
1.376M shares@ $24.45 avg price
DNTH
Dianthus Therapeutics Inc
Recent Activity
Increased 25.5%
7.54%
$31.325M
373,274 shares@ $83.92 avg price
RLAY
Relay Therapeutics Inc
Recent Activity
7.14%
$29.692M
2.984M shares@ $9.96 avg price
ANRO
Alto Neuroscience Inc
Recent Activity
Increased 494.69%
7.01%
$29.116M
1.325M shares@ $21.98 avg price
CNTA
Centessa Pharmaceuticals-adr
Recent Activity
Increased 528.04%
4.68%
$19.457M
489,849 shares@ $39.72 avg price
SVRA
Savara Inc
Recent Activity
Increased 40.32%
4.45%
$18.472M
3.383M shares@ $5.47 avg price
KALV
Kalvista Pharmaceuticals Inc
Recent Activity
Increased 131.39%
4.35%
$18.07M
897,681 shares@ $20.14 avg price
PCVX
Vaxcyte Inc
Recent Activity
Decreased -38.62%
3.44%
$14.278M
245,709 shares@ $58.12 avg price

1-10 of 28